FOLH1 and neoplasm: It was demonstrated that an increase in the mass of injected BQ0413 (i.e., a decrease in specific activity of the tracer) leads to the saturation of uptake in normal PSMA-expressing tissues with a minor impact on tumor uptake and decreased overall background.